T-cell immune adaptor SKAP1 regulates the induction of collagen-induced arthritis in mice  by Smith, Xin et al.
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SKAP1  is an  immune  cell  adaptor  that  couples  the T-cell  receptor  with  the  ‘inside-out’  signalling  pathway
for  LFA-1  mediated  adhesion  in  T-cells.  A connection  of SKAP1  to the  regulation  of  an  autoimmune
disorder  has  not  previously  been  reported.  In  this  study,  we  show  that Skap1-deﬁcient  (skap1-/-)  mice  are
highly resistant  to the  induction  of  collagen-induced  arthritis  (CIA),  both  in  terms  of  incidence  or  severity.
Skap1-/-  T-cells  were  characterised  by  a selective  reduction  in  the  presence  IL-17+ (Th17)  in response  toeywords:
-cells
KAP1
KAP-55
daptor
CII peptide  and a  marked  reduction  of joint  inﬁltrating  T-cells  in Skap1-/-  mice.  SKAP1  therefore  represents
a novel  connection  to Th17 producing  T-cells  and  is  new  potential  target  in  the  therapeutic  intervention
in autoimmune  and inﬂammatory  diseases.
© 2016  The  Author(s).  Published  by  Elsevier  B.V.  on  behalf  of European  Federation  of Immunological
Societies.  This  is an  open  access  article  under  the  CC  BY  license  (http://creativecommons.org/licenses/urine autoimmune arthritis
. Introduction
Rheumatoid arthritis (RA) is a chronic inﬂammatory disease that
ffects joints, causing cartilage and bone destruction. The disease
an be induced by the immunization of susceptible mice with type II
ollagen (CII) leading to humoral and cell-mediated responses [1,2].
rthritic severity in murine arthritis is correlated with autoan-
ibody responses to CII [3]. Further, CD4+ T cell involvement in
heumatoid arthritis (RA) has been inferred from linkage to HLA-
R alleles and the presence of activated CD4+ T cells in inﬂamed
oints [4]. Despite the success of Tumour necrosis factor-alpha
TNF-) blocking biologics in treating RA [2,5], novel therapies are
eeded to modulate the underlying immune response [2,6]. Murine
odels have been used in the pre-clinical testing of drugs such as
NF- blockade [5,7].
LFA-1 (lymphocyte function-associated antigen; L2) antag-
nists also reduce inﬂammation in murine arthritis [8]. LFA-1
n T cells binds ICAM-1/3 on antigen presenting cells [9,10],
nd its activation involves GTP-binding protein Rac-1 [11–15]
nd immune cell adaptors in T-cells termed ADAP (adhesion and
egranulation-promoting adaptor protein; also FYB: Fyn bind-
ng protein) and SKAP1 (Src-kinase-associated phosphoprotein1
r SKAP-55) [16]. SKAP1 has a pleckstrin-homology domain, a
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icense  (http://creativecommons.org/licenses/by/4.0/).by/4.0/).
C-terminal SH3 domain and tyrosine residues [17,18] and regu-
lates integrin clustering and adhesion [12,13,16,19,20] via the Rap1
binding to its partner, RAPL [16,21,22].
Despite its importance in T-cell function, a connection of SKAP1
to an autoimmune disorder has not been reported. Here, we show
that Skap1-deﬁcient mice are resistant to the induction of CIA,
as characterised by reduced pro-inﬂammatory cytokine IL-17. Our
ﬁnding indicates for the ﬁrst time a role for SKAP1 in regulating
inﬂammatory arthritis and suggests that the adaptor might serve
as a novel therapeutic target.
2. Results and discussion
2.1. Skap1-/- mice are less susceptible to collagen-induced
arthritis (CIA)
To assess the role of SKAP1 in the induction of CIA, Skap1+/+
and Skap1-/- mice were injected intradermally (i.d.) at two sites
into the base of the tail with a chicken type II (CII) in an emul-
sion of complete Freund adjuvant (CFA) and monitored for signs of
disease over 100 days (see Section 3). CII collagen can induce arthri-
tis in C57BL/6 mice with incidences of 50–70% [23–26]. Skap1+/+
and Skap1-/- mice have the same genetic background, and in many
cases, were littermates. We  found that CII collagen induced arthritis
in B6 mice with a maximum cumulative incidence of 70% and mean
day of onset between days 30 and 40 after primary immunization,
as reported [26] (Fig. 1A). By contrast, Skap1-/- mice showed a much
lower cumulative incidence of 10% (n = 18–22). The mean arthritic
ration of Immunological Societies. This is an open access article under the CC BY
X. Smith et al. / Immunology Letters 176 (2016) 122–127 123
Fig. 1. Skap1−/− mice are resistant to collagen induced arthritis. Collagen induced arthritis (CIA) was  induced in wild type mice and Skap1−/− mice as described in Section
3. Panel A: Skap1−/− mice show a reduced incidence of inﬂammation. Panel B: Skap1-/- mice show a reduced mean arthritis score. Reduced clinical scores in Skap1−/− mice
from  day 20–90. The Data shown in Panel A and B are from four pooled experiments. The presented results are the mean ± SEM.* p < 0.05, **p < 0.01. Panel C: Dot  plot of
individual arthritis scores of mice at day 40. Panel D: The body weight of Skap1−/− and WT mice from week 1–15. No difference in body weights was observed.
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Wcore was also lower in Skap1-/- mice from day 50–80 with a value
f 3.7 for Skap1+/+ mice and 0.4 for Skap1-/- mice (Fig. 1B). A dot
lot of different mice at day 40 showed the range of responses for
kap1+/+ vs. −/- mice with a mean that was consistently lower for
kap1-/- mice (p value = 0.0007) (Fig. 1C). No difference was  noted
n the body weight of Skap1+/+ and Skap1-/- mice (Fig. 1D). These
ata showed that the loss of SKAP1 conferred relative resistance of
ice to the induction of arthritis.
A histological assessment of joints showed that 60% of Skap1+/+
ice showed severe pathology, 10% moderate, 10% mild and
0% normal histology (Fig. 2A, upper and lower panels). Severely
ffected joints showed inﬂammatory cell inﬁltration and inva-
ive pannus tissue formation associated with bone and cartilage
egradation. By contrast, Skap–/– mice showed 85% in the normal
ategory when compared to the WT  mice (P < 0.001). The remaining
% showed either a mild and moderate pathology pattern. Overall,
hese ﬁndings showed that SKAP1 deﬁciency provides protection
gainst the induction of CIA. We  also examined the presence of T-
ells in the joints Skap1-/- and +/+ mice in response to CII. CD3+ T
ells were subjected to in situ staining of the joint area and revealed
 major reduction in the inﬁltration of T-cells in Skap1−/− mice
Fig. 2B; T-cells seen in brown color). Mice were immunized with
II and boosted at day 21, the mice were sacriﬁed at day 40, and
he joints were sectioned and stained with antibody. In a given
rea, 52 CD3+ T-cells were detected in skap1+/+ mice, and only 16
n skap1-/- mice (right histogram). There were no detectable T-cells
n non-diseased mouse joints.
.2. Reduced expression of IL-17 in T-cells of Skap1-/- miceTo investigate cytokine responses, inguinal LNs and spleen were
arvested on day 14 (early arthritis) post primary CII immuniza-
ion followed by intracellular staining for various cytokines (Fig. 3).
hen gated on CD3, Skap1-/- LNs showed a signiﬁcantly lowerpercent of IL-17 expressing cells with 15.5% relative to 22.6% for
Skap1+/+ cells (Fig. 3A, upper left panel). The MFI  for Skap1-/- T-
cells was  also lower (upper right panel). Similarly, only 5.6% of CD3
positive splenic Skap1−/− T-cells were positive relative to 10.7 for
Skap1+/+ T-cells (lower left panel). The MFI  was 6.2 for Skap1-/-
spleen T-cells relative to 11.7 for wild-type cells (lower right panel)
(n = 5). Likewise, when gated for CD4, Skap1-/- CD3+ spleen T-cells
showed a lower percentage of IL-17 positive cells with 7.2% versus
10.2% for Skap1+/+ T-cells (Fig. 3B, upper panel; Fig. S1). When gated
for CD8, 4.3% of Skap1-/- CD3+ T-cells expressed the cytokine rel-
ative to 9.0% of CD3+ Skap1+/+ T-cells. These data showed that
Skap1-/- T-cells have a lower prevalence of IL-17 expression in
response to CII immunization. Surprisingly, the expression of other
inﬂammatory or inhibitory cytokines such as IL-10, TNF-, IFN-,
and IL-2 was unaffected by the loss of SKAP1 (Fig. S2A). No dif-
ference was  noted in the expression of surface receptors such as
the differentiation marker CD62L or inhibitory co-receptors such
as PD-1 and LAG-3 (Fig. S2B). A difference was noted for CTLA-4
expression in T-cells from spleen but not lymph nodes.
As an additional control, anti-serum anti-C11 antibody levels
were assessed by ELISA (Fig. 3C). Blood was  collected from the retro-
orbital sinus at day 40 post-primary immunization, while bound
anti-collagen IgG was  detected with HRP-labelled goat anti-mouse
IgG. Skap1+/+ mice (WT) showed an average of 7.5 g/ml of anti-
CII antibodies, while a mean was  reduced to 5.4 g/ml in Skap1-/-
mice as averaged over 3 experiments. No signiﬁcant difference in
antibody production was seen between Skap1−/− and WT  mice,
consistent with the report that Th17 dervived IL-17 is dispensible
for antibody production [27].
Overall, our ﬁndings identify SKAP1 for the ﬁrst time as a key
regulator of CII induced RA in mice. Skap1-deﬁcient mice were
markedly resistant to the induction of CIA as characterised by a
reduction in the key pro-inﬂammatory cytokine IL-17. Both the
number of Th17 cells and the production of IL-17 were signiﬁ-
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Fig. 2. Joint histology of Skap1−/− vs Skap1+/+ (WT) mice. Panel A: Joint histology. Upper panels: Histological features of CIA. Sections of an untreated control (left panel),
severely arthritic Skap1+/+ (middle left), mild arthritic CIA-immunized Skap1−/− mouse (middle right) and moderately diseased Skap1−/− mouse (right panel) (×200 mag-
niﬁcation). Lower panel: Histogram of percentage of joints. SKAP1-/- (n = 504 joints) and WT (n = 556 joints) mice in each group. Data are from four pooled experiments.
***P  < 0.001 compared with the same histological grade in WT mice. (n = 18–22). Panel B: Skap1−/− mice show a reduced numbers of inﬁltrating T-cells in joints. Immunoper-
o icate C
h  from
s  reduc
c
i
b
S
r
e
g

cxidase staining of the tissue sessions with an anti-CD3 Ab. Dark brown cells ind
istogram showing the number of T-cells in joints on 0–50 scale. At least ﬁve areas
pecimen. T cells inﬁltration of the synovial area of Skap-1-/-mice was  signiﬁcantly
antly reduced, an effect that would be expected to reduce the
nﬂammatory response. This is also the ﬁrst reported connection
etween SKAP1 and the generation of Th17 cells. The ability of
KAP1 to mediate inﬂammatory responses is consistent with its
ole in mediating T-cell binding to antigen presenting cells and
nsuring oprtimal responses to antigen [12]. The exact integrin tar-
eted by Skap1 in resistence is not clear since the activation of both
1 and 2 integrins is impaired in skap1−/− T-cells [19,20]. Leuko-
yte recruitment to sites of inﬂammation is a multistep processD3-positive T cells (×40). Upper panel: images of stained sections; lower panel:
 each specimen were chosen to determine the numbers of T cell inﬁtrating in each
ed, compared with WT mice. P = 0.0005.
that involves the multiple adhesion molecules and their ligands
on leukocytes and the inﬂamed tissue. Antibody blocking studies
suggest that the LFA-1 I-domain mediates a critical interaction in
synovial inﬂammation, either to counterreceptors ICAM-1 (CD54)
or JAM-A in the synovial [28]. Disease onset and initial sever-
ity was affected in ICAM-1 null mice, but not ICAM-2 null mice.
Another report has shown a marked reduction in acute leuko-
cyte recruitment in CD18- and CD11a-deﬁcient mice in peritoneal
inﬂammation, but not in mice lacking CD18 [29]. Our ﬁndings are
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Fig. 3. Cellular and humoral responses to CII in mice. T-cells were removed from mesenteric lymph nodes at day 14 following CII injection and assessed for the various
cytokines by intracellular staining and ﬂow cytometry. Panel A: The number of CD3+ IL-17 expressing T-cells is reduced in Skap1-/- mice in response to CII. Upper panels:
lymph  nodes; lower panels: spleen. Left panels: Percentage of cells; right panels: mean ﬂuorescent intensity (MFI). Panel B: IL-17 expressing CD4 and CD8 cells reduced in
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fkap1-/- mice in response to CII. Upper panels: IL-17 expression in CD4+ T-cells; low
evels  of CII-speciﬁc IgG were determined in individual sera from SKAP1-/- (n = 18) 
ean±  SEM (n = 3).) *p < 0.05, **p < 0.01.
herefore consistent with a role for SKAP1 in facilitating the activa-
ion of LFA-1 adhesion in inﬂammation. It provides an alternative
arget to anti-LFA-1 in therapeutic intervention in inﬂammatory
rthritis.
Our ﬁndings are also compatible with the ﬁnding that SKAP1
s needed primarily in responses to lower afﬁnity or dose anti-
en [30,31]. We  previously showed that high TCR occupancy with
nti-CD3 can over-ride the dependency of LFA-1 activation on the
KAP1 adaptor [19]. At the same time, it was surprising that other
ytokines such as IL-10 were not affected. The rationale for this
electivity is unclear, but may  related to additional roles of SKAP1
n the inhibition of the p21-ERK pathway [32,33] and in ‘outside-in’
ignalling via integrins [13,34]. While the full range of mediators
ffected by these processes are unknown, the balance of positive
nd negative signals could alter the threshold of signalling favour-
ng the induction of one cytokine vs. another in different conditions.
he potency of the effect of the loss of SKAP1 also suggests that its
unction cannot be substituted by related Skap2 (Hom or related)els: IL-17 expression in CD8+ T-cells. Panel C: Serum anti-CII IgG levels. Circulating
T (n = 22) mice at 100 days after primary immunization with CII. Results show the
[35]. Overall, our ﬁndings suggest that SKAP1 may  be an attractive
target for therapeutic intervention in autoimmune and inﬂamma-
tory diseases.
3. Materials and methods
3.1. Collagen-induced arthritis (CIA)
C57BL/6J mice from Jackson laboratories (Bar Harbor, ME)  while
skap1-/- mice were derived as decribed in Refs. [19,36]. Chick type
II collagen, CII (Sigma) in Complete Freund adjuvant (CFA) was
injected intradermally (i.d.) at two  sites into tail base (100 l emul-
sion with 100 g CII and 250 g Mycobacterium tuberculosis) [7].
Injections were repeated on day 21 and joints were assessed for
swelling and restriction. Each paw was scored (0 indicates nor-
mal; 1, mild swelling; 2 extensive swelling; and 3, joint distortion
and/or rigidity; maximum score per mouse, 12). Joint histology was
examined by joints (knee, elbow, ankle and wrist) being harvested,
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xed in 10% formaldehyde/PBS forand decalciﬁed using EDTA for
 weeks. Specimens were cut longitudinally to the midline, and
 m sections mounted for staining with haematoxylin and eosin.
hese sections were graded in severity from 0 (normal) to 5 (severe)
or ﬁve components, including joint exudate, synovitis, panus for-
ation, cartilage degradation and bone degradation. Based on the
istological scores, joints were classiﬁed as demonstration inﬂam-
atory arthritis if there was an exudate score of 1 or more and
 synovitis score of 2 or more. Destructive arthritis was  deﬁned
or joints that scored 2 or more for pannus or 1 or more for either
artilage degradation or bone degradation.
T cell inﬁltration in the joint was determined by immunoperox-
dase staining of tissue sections with anti-CD3 (DAKO) for 1 h. DAB
taining kit (SK4100, Vector Laboratories) was used for color visual-
zation and counterstaining with hematoxylin and eosin. Five ﬁelds
ere randomly selected for each joint, and the average number of
nﬁltrating T cells was determined by adding the total number of
 cells, then dividing by ﬁve to obtain the number of inﬁltrating T
ells per ﬁled of each joint.
.2. CII-speciﬁc and cytokine responses
Isotype-speciﬁc anti-collagen Abs from retro-orbital sinus blood
as determined by ELISA on Immulon II plates (Dynex Technolo-
ies, Chantilly, VA). Bound anti-collagen IgG was detected with
RP-labeled goat anti-mouse IgG (Southern Biotechnology Asso-
iates, Birmingham, AL). Absorbance at 450 nm.
For cytokine production, T-cells from inguinal LNs or spleen
ere harvested at 14 days post immunization followed by intra-
ellular staining for TNF, IL-2 and IFN- and other cytolines (BD).
ifferences between mice was analyzed by a Mann-Whitney U test.
ll data are represented as mean ± SEM or SD and values of p < 0.05
ere considered statistically signiﬁcant. Flow cytometry was  also
onducted using antibodies to CD3, CD4, CD44, CD62L (BD, Cell
ignal) with Alexa conjugated secondary antibodies (Invitrogen).
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